2017 european union (eu) presidency event...

EAPM

2017

B E L F A S T

Cancer: A paradigm for Personalised Health

Big Data for Better Health

Personalised Health and Policy Agenda

Keeping the Person In Personalised Health

Personalised Health and Human Disease

Driving The Innovation Agenda

27 November 2017

10:00 – 10:30 Press Conference

10.30 – 11.15

Opening of EAPM Congress

Chair: Denis HorganExecutive Director, European Alliance for Personalised Medicine (EAPM) Brussels, Belgium

Welcome: David ByrneFormer European Commissioner for Health and Consumer Protection and Co-Chair EAPM, Brussels, Belgium

Toomas Hendrik IlvesFormer President of Estonia

Simon HarrisMinister of Health, Republic of Ireland

Jevgeni OssinovskiMinister of Health, Estonia

Cristian Silviu BusoiMember of the European Parliament, Brussels, Belgium

Minister of HealthNorthern Ireland (TBC)

Mary BakerFormer President, European Brain Council, Brussels, Belgium

Sue HagerSVP Corporate Communications and Government Aff airs, Foundation Medicine, Inc

11.15 – 13:00

Opening Plenary Presidential Session: Round Table"Growth in Personalised Healthcare – The promise for future generations"

Chair: Mark LawlerChair in Translational Cancer Genomics, Queen's University Belfast, UK

Desmond SchatzAssociate Chairman of Pediatrics, School of Medicine University of Florida, Gainesville, Florida USA

Kim StrattonHead International Commercial, Shire

Denis LacombeDirector General, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

Chris RoundHead of EMEA Region for Biopharma Global Commercial Operations, Merck

Lorraine NolanChief Executive, Health Products Regulatory Authority, Dublin, Ireland

Mary BakerFormer President European Brain Council, Brussels, Belgium

Proff ered Paper Presentation

EUROPEAN UNION (EU) PRESIDENCY EVENTEuropean Alliance for Personalised Medicine CongressPersonalising Your Health: A Global Imperative!

EAPM

2017

B E L F A S T







13.00 – 13:45 Lunch and Networking

13.45– 15.30 Parallel Sessions

13.45– 15.30

Centre for Cancer Research and Cell Biology 10 Year Anniversary Symposium

Chair: David WaughDirector, Centre for Cancer Research and Cell Biology, Belfast, UK

Owen SansomDeputy Director, Cancer Research UK Beatson Institute, Glasgow, UK

Denis LacombeDirector General, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

Jan KorbelGroup Leader, Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany


13.45– 15.30

The Value of Sustainable Healthcare

Chair: Denis HorganExecutive Director, European Alliance for Personalised Medicine, Brussels, Belgium

Stephane HoganHead of Sector for Neurosciences DG Research & Innovation, Brussels, Belgium

Giovanni EspositoEuropean Brain Council, Brussels, Belgium

Michela TinelliDepartment of Social Policy, London School of Economics, London, United Kingdom

Patrice BoyerPresident, European Psychiatric Association, Paris, France

Kim StrattonHead International Commercial, Shire

Anita MacDonaldConsultant Dietician, Inherited Metabolic Disorder, Birmingham Children's Hospital, United Kingdom


13.45– 15.30

European Hematology Association Session – Personalising treatment of blood diseases – Taking advantage of the leukemia/lymphoma genome

Chair: Ulrich JägerProfessor of Hematology, Medical University of Vienna, Austria

Personalisation in hematologyUlrich JägerProfessor of Hematology, Medical University of Vienna, Austria

The hematology research roadmapTorsten HaferlachCEO, Munich Leukemia Laboratory, Munich, Germany

Carin SmandDirector, EHA

Magda ChlebusDirector Science Policy, EFPIA. Brussels, Belgium

EAPM

2017

B E L F A S T







Access to Innovative MedicinesAnton HagenbeekUniversity of Amsterdam - Academic Medical Centre, The Netherlands


13.45– 15.30

Capturing the Global Picture in Precision Medicine

Chair: Richard BarkerCenter for the Advancement of Sustainable Medical Innovation (CASMI), Oxford/University College London, UK

Mark LawlerCentre for Cancer Research and Cell Biology, Queen's University Belfast, UK

Vineet DattaExecutive Director, Datar Genetics Limited, New Delhi, India

Luis MendaoChair of the the Board of GAT – Treatment Activist Group

Maarten IJzermanChair Department of Health Technology & Services Research, University of Twente, Netherlands

IC-PerMed PerspectiveAin AaviksooDeputy Secretary General for E-services and Innovation, Ministry of Social Aff airs, Estonia

Danish PerspectiveSpeaker to be confi med


13.45– 15.30

A Tale of Two Cities: a whole system approach to personalised medicine and health

Chair: Gianni D’ErricoEuropean Funding Offi cer, Regional Foundation for the Biomedical Research, Lombardy, Milan, Italy

Co-Chair: Michael Paul MessengerPrincipal Healthcare Scientist, Leeds Institute of Cancer & Pathology, Leeds, UK

PPM+ The Leeds Care Record: Big Data supporting PMGeoff HallChief Clinical Information Offi cer, Leeds Teaching Hospital NHS Trust, Leeds, UK

Early Health Economic Modelling – developing the evidence of valueBethany ShinkinsTest Evaluation Group Lead, University of Leeds, Leeds, UK

Overview of the management of people aff ected by chronic diseasePaolo MocarelliScientifi c Director of "don Gnocchi Foundation”, Milan, Italy

Prevention of Chronic diseases and benefi ts for the healthcare systemsProf. Giovanni TononDirector, Centre for Translational Genomics and BioInformatics, San Raff aele Institute, Milan, Italy

Public Consultation on PM in Lombardy Regions – Overviews and scientifi c, industrial and policy outcomesLuca del GobboRegional Ministry University, Research and Open Innovation, Milan, Italy

Accelerating PM and Health – a whole system approachMichael Paul MessengerPrincipal Healthcare Scientist, Leeds Institute of Cancer & Pathology, Leeds, UK


EAPM

2017

B E L F A S T







15.30 – 17.00

Presidential Session – Shaping Future Healthcare and the One Health Agenda I

Co-Chair: Alastair KentAmbassador, Genetic Alliance, UK

Sue Hill, OBEChief Scientifi c Offi cer, NHS England, UK

Sir John ChisholmExecutive Chair, Genomics England, UK

Mark Caulfi eldChief Scientist, Genomics England, Cambridge, UK

Ian YoungChief Scientifi c Advisor, Department of Health, Social Services and Public Safety, Belfast, Northern Ireland

Nathalie MollDirector General, EFPIA, Brussels, Belgium

Mike ThompsonChief Executive Offi cer, Association of British Pharmaceutical Industries, UK

17.00 – 17:15 Coff ee, Posters and Networking

17.15 – 19.00

Presidential Session – Shaping Future Healthcare and the One Health Agenda II

Chair: Peter Hongaard AndersonInnovation Fund, Denmark

Atul GawandeProfessor of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, USA

Richard Barker, OBECenter for the Advancement of Sustainable Medical Innovation (CASMI), University of Oxford/University College London, UK

Koen KasProfessor of Biochemistry, University of Gent, Belgium

19.00- 20.00

Special lecture

Chair: Gordon McVieSecretary EAPM

Alexander EggermontDirector General, Institute Gustave Roussy, Paris, France

20:30 – 22:00

Welcome Reception, Belfast City Hall (hosted by Lord Mayor)

James BrokenshireSecretary of State, Northern Ireland

Toomas Hendrik IlvesFormer President of Estonia

EAPM

2017

B E L F A S T







28 November 2017

07:30 – 08:15 Highlights of the Day and Press Briefi ng

08:30 – 10:00

Presidential Session: Big Data Saves Lives

Co-Chair: Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK and Co-Chair Clinical Cancer Genome Task Team, Global Alliance for Genomics and Health (GA4GH)

Co-Chair: Julia WilsonAssociate Director, Welcome Trust Sanger Centre Cambridge UK and Global Alliance for Genomics and Health (GA4GH)

Ewan BirneyDirector European Bioinformatics Institute, Cambrdge UK and Chair Global Aliance for Genomics and Health

Ain AaviksooDeputy Secretary General for E-services and Innovation, Ministry of Social Aff airs, Estonia

Ernst HafenInstitute of Molecular Systems Biology, ETH Zurich, Switzerland

Margaret GraysonChair Northern Ireland Cancer Research Consumer Forum, Belfast, UK

Andrew MorrisDirector Health Data Research UK

Mene PangalosExecutive Vice President Innovative Medicines and Early Development Biotech Unit, AstraZeneca Cambridge, UK

10:00 – 10:30 Coff ee, Posters and Networking

10:00 – 10:30

Speed Networking

Meet the Cancer Patient

Ken MastrisChairman of the

Board, Europa Uomo

Meet the Business Leader

Peter MeeusHead of Region Europe, Shire

Meet the Big Data Expert

Ewan BirneyDirector European

Bioinformatics Institute, Cambridge

UK and Chair GA4GH

Meet the Policy Maker

Ain AaviksooDeputy Secretary

General for E-services and

Innovation, Ministry of Social Aff airs,

Estonia

Meet the Professor

Mark LawlerChair in Translational

Cancer Genomics, Queen's University

Belfast, UK

10:30 – 12:15 Parallel Sessions

10:30 – 12:15

Solving the challenges for manufacturing personalised medicines at an industrial scale

Manufacturing processes of the futureJohn MilneTraining Director, National Institute for Bioprocessing Research and Training (NIBRT), Dublin, Ireland

The future workforceKillian O’DriscollDirector of Projects at NIBRT, Dublin, Ireland

EAPM

2017

B E L F A S T







Andrew WhytockIndustry 4.0 and Digitalization lead, Pharmaceutical Business Segment, Siemens AG

Prof Kieran HodnettScientifi c Director and Principal Investigator SSPC, University Limerick

Matt MoranDirector, BioPharmaChem Ireland


10:30 – 12:15

Ulster University Session on Precision Medicine in Multi-morbid Inflammatory Disease

Chair: Tony BjoursonDirector, Northern Ireland Centre for Stratifi ed Medicine, Biomedical Sciences Research Institute, Ulster University, Derry, UK

Stratifi ed Medicine in Proinfl amatory Multi-morbid DiseaseTony BjoursonDirector, Northern Ireland Centre for Stratifi ed Medicine, Biomedical Sciences Research Institute, Ulster University, Derry, UK

A Gut Feeling about Mental Health: Precision Medicine and the MicrobiomeJohn F. CryanChair, Department of Anatomy and Neuroscience, Principal Investigator APC Microbiome Institute, University College Cork, Ireland

Personalised Medicine approaches to immunological mechanism and treatment for major psychiatric disordersGolam KhandakerWellcome Trust Intermediate Clinical Fellow, Department of Psychiatry, University of Cambridge, UK


10:30 – 12:15

Centre for Experimental Medicine (CEM) Queen's University Belfast Special Session: Eyes do not lie – you are what you can see! Options for personalised medicine in eye diseases

Chair: Tunde PetoCentre for Experimental Medicine, Queen’s University Belfast, UK

Pharmacogenetics and the individual patient: the industry perspectiveEverson NogocekeBiomarker Experimental Medicine Leader, Roche Pharma Research & Early Development, Roche, Basel, Switzerland

Precision Ophthalmology: Lessons from age related macular diseaseCarel HoyngProfessor of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

The myopia epidemic: can we individualise the message?Caroline KlaverProfessor of Ophthalmology at Erasmus MC & Radboud UMC The Netherlands

Micronutrients and age related eye disease: from diet through drugs to prevention of blindnessImre LengyelCentre for Experimental Medicine, Queen’s University Belfast, UK

Curing diabetic eye disease? - from the bench to treating patients as individualsAlan StittProfessor, Centre for Experimental Medicine, Queen’s University Belfast, UK

How to improve imaging technology to accommodate individual needs?Anne-Marie CairnsGlobal Vice President of Clinical & Medical Aff airs, Optos, Halbeath, UK


EAPM

2017

B E L F A S T







10:30 – 12:15

European Bioinformatics Institute-Global Alliance for Genomics and Health (GA4GH) Special Session Empowering personalised health through data sharing

Chair & Welcome: Julie WilsonAssociate Director, Welcome Trust Sanger Centre, Cambridge, UK; Clinical Working Group, Global Alliance for Genomics and Health (GA4GH)

Thomas KeaneTeam Leader: EGA, EVA and archive infrastructure EMBL-EBI

Torsten SchwedeProfessor of Bioinformatics, Swiss Institute of Bioinformatics, University of Basel, Switzerland

Sarion BowersPolicy Lead Sanger Institute

Jeff BarrettDirector, Centre for Therapeutic Target Validation, Cambridge, UK


10:30 – 12:15

Converting Hospitals to a Personalised Health Agenda

Chair: Pascal GarelChief Executive, Hospital and Healthcare Federation (HOPE), Brussels, Belgium

Regional LevelEva Weinreich-JensenVice-President, HOPE & Senior Advisor, Danish Regions, Denmark

From Carpet Bombing to Sniper Fire: Genomics to Precision Cancer Care in Children and AdolescentsProf. Giovanni TononDirector, Centre for Translational Genomics and BioInformatics, San Raff aele Institute, Milan, Italy

Manuel Salto-TellezProfessor of Pathology, Centre for Cancer Research and Cell Biology, Queen's University Belfast, UK

Stephen McMahonChairman and co-founder of the Irish Patients' Association (IPA), Dublin, Ireland


12:30 – 13:30 Lunch, Posters and Networking

13:00 – 14:30

Presidential Session: Research Frontiers in Personalised Medicine

Chair: Denis HorganExecutive Director, European Alliance for Personalised Medicine (EAPM) Brussels, Belgium

Mairead O’DriscollHealth Research Board of Ireland, Dublin, Ireland and IC-Per Med

Alberto BardelliPresident Elect, European Association for Cancer Research, Torino, Italy

Peter KeelingChief Executive Offi cer, Diaceutics

Gennaro CilibertoScientifi c Director, IRCCS, Instituto Nazionale Tumori “Regina Elena, Rome, Italy

Stephen M RobbinsScientifi c Director, CIHR Institute of Genetics, Montreal, Canada

EAPM

2017

B E L F A S T










14:30 – 15:00

Speed Networking

Meet the Patient

representative

Lydia Makaroff Director, ECPC

Meet the Research Expert

Mairead O’DriscollHealth Research Board of Ireland,

Dublin, Ireland and IC-Per Med

Meet the Epidemiologist

Michel ColemanProfessor of

Epidemiology and Vital Statistics, Department of

Non-Communicable Disease

Epidemiology, London School of

Hygiene and Tropical Medicine, London, UK

Meet the Scientist

Gennaro CilibertoScientifi c Director,

IRCCS, Instituto Nazionale Tumori

“Regina Elena, Rome, Italy

Meet the Oncologist

Fabien CalvoScientifi c Director,

Cancer Core Europe, Paris, France: SAP Health – Institute Gustave Roussy


15:00 – 16:30

Mini Symposium: Breast Cancer: Dealing with Complexity Head on to Better Personalised Treatment

Chair: William GallagherDirector Conway Institute for Biomolecular Research, University College Dublin, Ireland

Michael J. Duff yAdjunct Professor, School of Medicine and Medical Science, University College Dublin, Ireland

Ivana SestakLecturer in Medical Statistics, Wolfson Institute of Preventitive Medicine, Queen Mary University of London, UK

Fergus CouchChair, Division of Experimental Pathology, Mayo Clinic, Rochester, Minnesota, USA


Iñaki Gutiérrez-IbarluzeaVice President en Health Technology Assessment international (HTAi), Basque Region Spain


15:00 – 16:30

Genomics and Medicine – Crossing the Rubicon

Chair: Shane McKeeDirector Northern Ireland Genomics Medicine Centre, Belfast, UK

Sir John BurnProfessor of Clinical Genetics University of Newcastle, UK

Andrew SpiegelExecutive Director, Global Colon Cancer Assocation, Philadelphia, USA

Daniel SchneiderDirector Diagnostics and Personalised Medicine, Teva Pharmaceuticals

EAPM

2017

B E L F A S T







Involving the public in conversations about Genomics: making Personalised Medicine resonateAnna MiddletonHead of Society and Ethics Research Wellcome Genome Campus, Cambridge, UK


15:00 – 16:30

Realising precious therapeutics in neurological disease

Chair: Gianpiero CavalleriAssociate Professor in Human Genetics Royal College of Surgeons in Ireland, Dublin, Ireland

Slave PetrovskiNHMRC Fellow, Royal Melbourne Hospital, University of Melbourne, Australia

eHealthMary FitzsimonsMedical Physicist, Beaumont Hospital, Dublin, Ireland

Clinical integrationNorman DelantyProfessor of Clinical Neurological Sciences, Beaumont Hospital, Dublin, Ireland


15:00 – 16:30

Innovation, Screening, Guidelines: The Case of Lung Cancer

John FieldProfessor of Molecular Oncology, University of Liverpool, UK

Dr Gerry HannaSenior Lecturer and Consultant in Clinical Oncology Centre for Cancer Research and Cell Biology, Queen's University of Belfast, UK

Antoni MontserratSenior Expert on Cancer and Rare Diseases, DG Public Health, European Commission, Brussels, Belgium

Stefania ValloneLuCE (Lung Cancer Europe), Bern, Switzerland

Mina GagaPresident Elect, European Respiratory Society, Athens, Greece

Aad Van der LugtProfessor of Neuroradiology and Head/Neck Radiology, Erasmus MC, Rotterdam, The Netherlands

Oudkerk MatthijsScientifi c Director Centre for Medical Imaging – North East Netherlands; Principal investigator NELSON STUDY: Dutch-Belgian study on lung cancer screening


15:00 – 16:30

The most dreadful “neglected” cancer: pancreatic cancer

Personalized genomics medicineAndrew BiankinRegius Chair of Surgery/Director of Translational Research Centre, University of Glasgow

The patient's perspectiveAli StuntFounder of Pancreatic Cancer Action

The Family's and society's perspectiveLydia Makaroff Director, ECPC

EAPM

2017

B E L F A S T







Diagnostic challengesMatthias LohrProfessor of Gastroenterology & Hepatology, Dept. of Clinical Research, Intervention and Technology, Centre of Biosciences, Karolinksa Institutet, Stockholm, Sweden

Treatment progressesAlfredo CarratoProfessor of Medical Oncology, Institution Ramon y Cajal University Hospital, Madrid, Spain

Research gaps and needsNuria MalatsGroup Leader, Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre, Madrid, Spain


16:30 – 17:30

Special Lecture“Keeping the person in personalised healthcare”

Gretchen Rubin, Author, Blogger



17:30 – 19:00

Cancer in Europe : Responding to the Challenge

Situation in Eastern EuropeMark LawlerCentre for Cancer Research and Cell Biology, Queen's University Belfast, UK

Richard SullivanDirector, Institute of Cancer Policy, King's College London UK

Marius GaentaCo-Founder, Center for Innovation in Medicine, Bucharest, Romania

Jana PelouchovaSecretary, European Cancer Patient Coalition

Arnie PurushothamDirector of King’s Health Partners Cancer Centre (KHPCC), Chair of Breast Cancer at King’s College London (KCL) Trust (TBC)

Florin BuicuPresident Health Commission, Chamber of Deputies, Romanian Parliament

Beata JagielskaMaria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology; Department of Oncological Diagnostic , Cardio-Oncology and Palliative Care, Warsaw, Poland


17:30 – 19:00

Big data in hematology; accelerating more efficient drug development, regulatory evaluation, access appraisal and treatment strategies (HARMONY)

Introducing the HARMONY AllianceCarin SmandDirector, EHA

Patricia van DijckDirector Healthcare Systems Solutions Novartis Oncology Region Europe, Novartis

Inspirational keynote: Big data & Health ~ Big Data & HematologyEgge van der PoelDirector, Institute of Cancer Policy, King's College London UK

EAPM

2017

B E L F A S T







Debate: How to apply Big Data in patient care, regulatory systems and drug approval processes? Big data & Hematology: what are the specifi cs we need to take into account?

Multi-stakeholder panelJan GeisslerDirector, EUPATI

Pam BaconExecutive Director Medical Aff airs, Celgene

Gert OssenkoppeleProfessor of Hematology, VU University Medical Center

Alison CavePharmacovigilance and Epidemiology Department, EMA


17:30 – 19:00

Clinical Innovation Showcase: ‘Northern Ireland Clinical Research Network(NICRN) : supporting clinical research in personalised medicine’

Co-Chairs: Paul Biagioni, Maurice O’KaneNICRN

IntroductionMaurice O'KaneNICRN

Cardiovascular Disease (Exact title TBC)Patrick DonnellyCo-clinical Lead of the Northern Ireland Cardiovascular Research Network, South Eastern Health and Social Care Trust, UK

Diabetes (Exact title TBC)Vivien CoatesProfessor of Nursing Research, Ulster University, Coleraine, UK

Renal disease (Exact title TBC)Peter MaxwellProfessor of Renal Medicine, Queen's University Belfast, UK

Neil MorganConsultant Nephrologist, Newry, UK


17:30 – 19:00

Systems medicine, big data and scientific wellness: transforming healthcare—a proteomics view

Chair: Prof Stephen R PenningtonProfessor of Proteomics, UCD, President Elect HUPO


17:30 – 19:00

Personalised Health and rare disease

Chair: Alastair KentChair Rare Disease UK; Ambassador, Genetic Alliance UK

Sophie PapaKing's College London and Guy's and Thomas' NHS Foundation Trust, London, UK

Anders OlausonChair, NGO Committee for Rare Diseases, United Nations, New York

EAPM

2017

B E L F A S T







Maria Luisa SilvaDirector of United Nations Development Program (UNDP) Offi ce in Geneva, Switzerland (TBC)

Ana RathDirector, Orphanet, Paris, France

Peter MeeusHead of Region Europe, Shire


19:00 – 20:00Patrick Johnston Memorial Lecture

Paul Workman, Chief Executive and President, The Institute of Cancer Research (ICR), London, UK

19:00 – 20:00 Poster Session

20:30 – 22:30

Gala Dinner Titanic Belfast

Judge Fidelma Macken SCFormer judge of the Supreme Court of Ireland and a former judge of the European Court of Justice, Dublin, Ireland

Taavi Rõivasformer leader of the Reform Party and former Prime Minister of Estonia

29 November 2017


08:00 – 09:30

Presidential Session: Is precision medicine the route to a healthy world?

Chair: Alastair KentAmbassador, Genetic Alliance, UK

Taavi RõivasFormer leader of the Reform Party and former Prime Minister of Estonia

Chris FearneMaltese Minister for Health

Tom LillieVice President, Head of European Clinicial Development MSD, London, UK

Eelko den BreejenInternational Health Policy Leader, Personalised Healthcare, Roche

Francesco De LorenzoPresident, European Cancer Patient Coalition, Brussels, Belgium

Michel ColemanProfessor of Epidemiology and Vital Statistics, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK


EAPM

2017

B E L F A S T








10:00 – 11:30

Personal Oncology Approaches - reflections from both sides of the pond

Chair: Etienne RicherAssociate Director, CIHR Institute of Genetics, Montreal, Canada

Fabien CalvoScientifi c Director, Cancer Core Europe, Paris, France: SAP Health – Institute Gustave Roussy

Personalized Cancer ImmunotherapyDenis Claude RoyDirector Cellular Therap Laboratory, Scientifi c Director, Centre de recherche, Hospital Maisonneuve-Rosemont, Montreal, Canada

Personalized Oncogenomics (POG), The BC Cancer Agency’s Personalized Oncogenomics ProgramMarco MarraDirector and Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Ian WalkerRoche Foundation Medicine Commercial Leader - Region Europe, Basel, Switzerland


10:00 – 11:30

The ‘molecularly unstratified’ patient: a focus for moral, psycho-social and societal research

Chair: Lisa WildeDirector of Research and External Aff airs, Bowel Cancer UK

Tim MaughanProfessor of Clinical Oncology, University of Oxford; MRC/CRUK Stratifi cation in Colorectal Cancer Consortium

Joshua HordernAssociate Professor of Christian Ethics, University of Oxford; Oxford Healthcare Values Partnership, University of Oxford

Richard SullivanChair in Cancer Policy and Global Health, Kings College London

Alison HallHead of Humanities, PHG Foundation, Cambridge, UK

Liz MorrellPostdoctoral researcher, Centre for the Advancement of Sustainable Medical Innovation (CASMI), Radcliff e Department of Medicine, University of Oxford, UK

Rob HorneProfessor of Behavioural Medicine, UCL School of Pharmacy; Centre for the Advancement of Sustainable Medical Innovation, London, UK

Alastair KentChair Rare Disease UK; Ambassador, Genetic Alliance UK


10:00 – 11:30

Regulatory Environment for Diagnostics necessary for precision medicine

Chair: Jonathan TrueloveVice President, General Counsel – International, Genomic Health, Geneva, Switzerland

Sheila Walcoff Founder and CEO, Goldbug Strategies, Washington, USA

EAPM

2017

B E L F A S T







Stephen LeeBiosciences Team Manager, Medicines and Healthcare products Regulatory Agency, London, UK (TBC)

Sue SpencerHead of Global Medical Device Services, UL, UK (TBC)

Vincent HoudryLegal Offi cer, DG for Internal Market, Industry, Entrepreneurship and SMEs, Unit Health Technology and Cosmetics

British Standards Institution representative

Speaker to be confi rmed

Armin RitzhauptScience and Innovation Support Offi ce, Product Development Scientifi c Support Department, European Medicines Agency

Frederique NowakHead of the Department of Biology, Transfer and Innovations, Research and Innovation Directorate, Institut National du Cancer (INCa), France


10:00 – 11:30

Discover what's possible - Cross border healthcare

Speakers to be confi rmed


10:00 – 11:30

Preserving Health – what can we do at European Level?

Chair: Tit AlbrechtInstitute of Public Health, Slovenia

Sebastian SchmidtHead of Strategy and Medical Aff airs Computed Tomography at Siemens Healthineers

Public health genomicsMarc Van den BulckeHead Cancer Centre, OD Public Health and Surveillance Scientifi c Institute of Public Health, Belgium

Survivorship issuesDr Claudia FerrariDepartment of Training and Demography for Health Professionals, The French National Cancer Institute (TBC)



13:30 – 15.00

Presidential Session: Leaders and Innovators Forum; An Athena Swan Initiative

Chair: Gordon McVieSecretary EAPM

Francoise MeunierDirector of Special Projects, European Association for the Research and Treatment of Cancer, Brussels, Belgium, Vice-President, Federation of European Academies of Medicine, Brussels, Belgium

Karen KnudsonDirector- NCI-Designated Sidney Kimmel Cancer Center, Thomas Jeff erson University, Philadelphia, USA

Stephen FriendChairman, Co-Founder and Past President Sage Bionetworks; Leader Health Team, Apple Inc.

EAPM

2017

B E L F A S T







Christophe Le TourneauSenior medical oncologist, Institut Curie and Professor of Medicine, Versailles-Saint-Quentin-en-Yvelines University

Christine ChomienneDirector of Research & Innovation, INCa, France

Patient Advocacy Award



15:00 – 16:30

Systems Medicine and Personalised Health

Nuria MalatsGroup Leader, Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre

Walter KolchDirector, Systems Biology Ireland, University College Dublin , Ireland (TBC)

Dan LongleyChair of Cancer Biology, Queens University Belfast, UK

Jochen PrehnDirector, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland


15:00 – 16:30

Personalised Medicine and Public Health: Two Sides of the Same Coin?

Chair: Walter RicciardiInstituto Superiore di Sanità Italy

Derick MitchellChief Executive, IPPOSI, Dublin, Ireland

Frank KeeDirector, UKCRC Centre for Excellence for Public Health Research (NI), Queen's University Belfast, UK

Kaisa ImmonenDirector of Policy, European Patient Forum

Peggy MaguireFormer President, EPHA; Director General, European Institute of Women's Health

Jerome FoucaudResponsible department of Human Sciences, epidemiology and Public Health, Institut National du Cancer (INCa), France


15:00 – 16:30

Fixing Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): Targeting therapies which make a difference

Co-Chair: J Stuart ElbornImperial College and Royal Brompton Hospital, London and Queen's University Belfast, UK

Co-Chair: Lorraine MartinProfessor of Molecular Pharmaceutics, School of Pharmacy, Queen's University Belfast, UK

How the Cystic Fibrosis Transmembrane Regulator (CFTR) worksLorraine MartinProfessor of Molecular Pharmaceutics, School of Pharmacy, Queen's University Belfast, UK

EAPM

2017

B E L F A S T







Modulating the Cystic Fibrosis Transmembrane Regulator (CFTR): How New Drugs were developedMark HigginsVertex, Boston, US

Treating Cystic Fibrosis: New Clinical TrialsJ Stuart ElbornImperial College and Royal Brompton Hospital, London and Queen's University Belfast, UK

Living with Cystic FibrosisMichelle Francis NaylorBelfast, UK

Future Challenges, Policy and ScienceJanet AllenDirector of Strategic Innovation, Cystic Fibrosis Trust, Southampton, UK


15:00 – 16:30

Health Literacy: A Key Component of Personaised Health and Innovation

Chair: Denis HorganEuropean Alliance for Personalised Medicine, Brussels, Belgium

Holger MochMedical Director and Chairman, Department of Pathology & Molecular Pathology, University Hospital Zurich, Switzerland

Stephen McMahonChairman and co-founder of the Irish Patients' Association (IPA)

Kristine SørensenFounder, Global Health Literacy Academy, The Netherlands

Geoff rey HenningPolicy Director, EuropaColon, Brussels, Belgium

Industry Speaker to be confi rmed


15:00 – 16:30

Genomics, DNA and Diaspora

Chair: Eimear KennyAssistant Professor, Icahn School of Medicine at Mount Sinai, NY, USA

Joe McHugh TDMinister of State for the Diaspora and International Development (TBC)

John GreallyProfessor, Faculty Scholar for Epigenetics, Albert Einstein College of Medicine, New York, USA

Dan BradleyPrincipal Investigator, molecular Population Genetics, Smurfi t Institute of Genetics, Trinity College Dublin

Eimear KennyAssistant Professor, Icahn School of Medicine at Mount Sinai, NY. USA

Tõnu EskoDeputy Director of Research, Estonian Biobank, Estonian Genome Center, University of Tartu, Estonia (TBC)



EAPM

2017

B E L F A S T







Speed Networking

Meet the Public Health Expert

Walter RicciardiInstituto Superiore

di Sanità Italy

Meet the Pancreatic

Expert

Nuria MalatsGroup Leader, Genetic and Molecular

Epidemiology Group, Spanish National Cancer Research Centre

Meet the Health Literacy Expert

Kristine SørensenFounder, Global Health Literacy Academy, The Netherlands

Meet the Genomic Expert

Dan BradleyPrincipal

Investigator, molecular

Population Genetics, Smurfi t Institute

of Genetics, Trinity College Dublin

Meet Patient Representative

Geoff rey HenningPolicy Director, EuropaColon,

Brussels, Belgium

17:30 – 19:00

Shooting for the Moon or Flying too near the Sun: Crossing the Value Rubicon in Precision Care

Co-Chair: Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK

Co-Chair: Richard SullivanDirector, Institute of Cancer Policy, King’s College London UK

Richard SullivanDirector, Institute of Cancer Policy, King’s College London UK

Tito FojoProfessor of Medicine, Columbia University, New York, USA

Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK

Virginia AchaExecutive Director, Research, Medical and Innovation, Association of the British Pharmaceutical Industry (ABPI), UK

19:00 – 20:00 Poster Session

20.00 - late Whiskey tasting and Special Performance

30 November 2017


08:00 – 09:30

Presidential Session: Personalised Medicine Through Open Innovation

Chair: Pierre MeulienInnovation Medicines Initiative (IMI)

U-BIOPRED Project – Peter SterkProfessor, Department of Respiratory Medicine in the Academic Medical Centre (AMC) of the University of Amsterdam

EU – AIMS Project - Declan MurphyProfessor of Psychiatry and Brain Maturation, University College London

CANCER – ID Project - Barbara BaggianiChief Marketing Offi cer, Silicon Biosystems - A Menarini Group Company

EAPM

2017

B E L F A S T









10:00 – 11:30

The Challenges of Precision Oncology Drug Development and Implementation

Co-Chair: Andrew BiankinRegius Chair of Surgery/Director of Translational Research Centre, University of Glasgow

Co-Chair: Simon HollingsworthExecutive Director Oncology; Global Project Director, AstraZeneca, Cambridge, UK

Challenges of Contemporary Therapeutic DevelopmentSimon HollingsworthExecutive Director Oncology; Global Project Director, AstraZeneca, Cambridge, UK

Diversity and Defi ning Actionability of Molecular EventsPhilip BeerPrecision oncology, cancer genomics and next-generation therapeutics - Cure Forward Corp., Cambridge, UK

Finding patients for trials/Finding Trials for PatientsIBM Watson Speaker(TBC)

Eff ective Strategies for approval and adoptionRobert Hemmings / Krishna PrasadMHRA (TBC)

Composite Datasets and Knowledge BanksAndrew BiankinRegius Chair of Surgery/Director of Translational Research Centre, University of Glasgow, UK


10:00 – 11:30

Connected Health – Defining the Vision and Business in a Changing Environment

Brian O'ConnorChair, European Connected Health Alliance

Jim McLaughlin OBEUniversity of Ulster, Northern Ireland

Dr Mike ScottMedicines Optimisation Innovation Centre, Northern Ireland

Professor George Crooks OBECEO, Digital Health &Care Institute, Scotland


10:00 – 11:30

We are what we eat – preserving health through enhanced nutrition

Chair: Christopher ElliottChair of Food Safety & Microbiology, Pro Vice Chancellor Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast, UK

Precision Nutritional Catering for the Vulnerable: Can this be achieved?Moira DeanInstitute for Global Food Security, Queen’s University, Belfast

Delivering a breakthrough in human nutrition and health through delivery of omega oils in chicken meatAlice StantonRoyal College of Surgeons in Ireland, Dublin, Ireland


EAPM

2017

B E L F A S T







10:00 – 11:30

Precision Pathology in LMICs - unaffordable luxury or relevant necessity?

Chair: Kenneth FlemingSenior Advisor for Pathology, Centre for Global Health NCI, Washington

Kenneth FlemingSenior Advisor for Pathology, Centre for Global Health NCI, Washington

Richard SullivanDirector, Institute of Cancer Policy, King’s College London UK

Mark LawlerChair in Translational Cancer Genomics, Queen's University Belfast, UK

Sue HortonProfessor and GICI Chair in Global Health Economics, University of Waterloo, Canada (TBC)

Round Table Discussion


10:00 – 11:30

HTA, Payers & the European Medicines Agency – Crossing the Rubicon

Chair: Denis HorganEuropean Allaince for Personalised Medicine, Brussels, Belgium

Co-Chair: Lou GarrisonUniversity of Washington, USA

Clare HagueDirector of Health Economics & Outcomes research Medical Aff airs, Celgene

Carole LongsonDirector, Centre for Health Technology Evaluation and Executive Director, National Institute for Health Care & Excellence (NICE), London, UK

Dr Charlie NichollsHead of Health Outcomes, Sanofi



13:00 – 14:30

Presidential Session: Regulating the future – Balance ofpatient safety and facilitating Innovation (EMA – FDA)

Chair: Denis HorganExecutive Director, European Alliance for Personalised Medicine

Louis GarrisonPast President, International Society For Pharmacoeconomics and Outcomes Research, Washington DC, US

Juergen Scheuenpfl ugGlobal Head Clinical Biomarkers & Companion Diagnostics, Merck

Urve PaloMinister of Entrepreneurship and Information Technology, Estonia (TBC)

Iñaki Gutiérrez-IbarluzeaVice President en Health Technology Assessment international (HTAi), Basque Region Spain

Maura O’DonovanSenior Medical Offi cer, Health Products Regulatory Authority, Dublin, Ireland


EAPM

2017

B E L F A S T







Speed Networking

Meet the HTA Expert

Iñaki Gutiérrez-Ibarluzea

Vice President en Health Technology

Assessment international (HTAi),

Basque Region Spain

Meet the Economist

Louis GarrisonPast President, International Society For

Pharmacoeconomics and Outcomes

Research, Washington DC, US

Meet the Pathologist

Kenneth Fleming, Senior Adviser for Pathology, Centre for Global Health NCI, Washington

Meet the Industry

Representative

Eelko den BreejenInternational Health

Policy Leader, Personalised

Healthcare, Roche

Meet the Patient

Representative

Peter KapiteinInspire2Live, The

Netherlands


15:00 – 16:30

EAU Special Session Every Prostate cancer is unique: Personalised prostate cancer diagnosis and management

Chair: Hendrik Van PoppelEuropean Association of Urology

Nicolas MottetUrology Department Head at CHU St Etienne - Université Jean Monnet, St Etienne, France

Rodolfo MontironiChairman, EAU Section of Uropathology (ESUP), Ancona, Italy

Thorsten BachChairman EAU Patient Information Projekt, European Association of Urology

Ian BanksPresident, European Men's Health Forum


15:00 – 16:30

The Value of Innovation from the Cancer Patient Perspective

The Value of Innovation from the Cancer Patient PerspectiveLydia Makaroff Director, ECPC, Brussels, Belgium

Access to Immuno-Oncology and other Innovations for People with Cancer in the United KingdomAndrew WinterbottomTreasurer of ECPC and Director of Fight Bladder Cancer UK

European Guide on Quality Improvement in Comprehensive Cancer ControlStephen HalloranUniversity of Surrey, Surrey, UK

Disinvestment and inequalities in oncologyMark LawlerQueen's University Belfast, Northern Ireland

The Cancer Innovation ChallengeGillian DochertyCEO, The Data Lab

Panel Discussion with key stakeholders


EAPM

2017

B E L F A S T







15:00 – 16:30

Diabetes: A Personalised Health Epidemic

Chair: Olivier ArnaudSenior Director, Juvenile Diabetes Research Foundation

Pediatric vs Adult onset Type 1 Diabetes – Clinical Considerations in Therapy DevelopmentColin DayanProfessor of Clinical Diabetes and Metabolism, Cardiff University, UK

Staging Type 1 Diabetes and its Prevention through Innovative InterventionsAke LernmarkM.D., LU Diabetes Centre, Lund University, Sweden

Realizing the Potential of Novel Interventions in Type 1 DiabetesThomas DanneM.D., Diabetes Centre for Children and Adolescents, Hannover, Germany


15:00 – 16:30

Molecular Diagnostics – Enabling the Personalised Medicine Revolution

Co-Chair: David BartonNational Centre for Medicial Genetics Crumlin

Co-Chair: Mario PazzagliUniversity of Florence, Italy

The new IVD regulationDavid BartonChief Scientist, National Centre for Medical Genetics Crumlin

A Workfl ow for molecular diagnostics in clinical oncologyMario PazzagliProfessor of Clinical Biochemistry, Department of Clinical and Experimental Biochemical Science University of Florence, Italy (TBC)

Flushing out the truth! Development of a multiplex urinary tract infection detection testMartin CrockardMolecular Diagnostics Manager, Randox Laboratories Ltd, Antrim , UK

Benchmarking the quality of next generation sequencing in Clinical OncologySimon PattonDirector at European Molecular Genetics Quality Network (EMQN) - European Molecular Genetics Quality Network (EMQN) (TBC)


15:00 – 16:30

CCRCB – ALMAC Session – The Realities of Delivering Personalised Medicine in Clinical Trials

Chair: Richard KennedyMcClay Professor in Medical Oncology Queen’s University Belfast, UK

Darren HodgsonSenior Principal Translational Scientist, AstraZeneca, Stcckport, UK

Matt SquiresExecutive Director Oncology Precision Medicine Novartis, Basel, Switzerland


EAPM

2017

B E L F A S T







16:30 – 17:30

Closing of conference: Keeping the promise and preparing for the future

Jevgeni OssinovskiMinister of Health, Estonia

David ByrneChair European Alliance for Personalised Medicine, Brussels, Belgium

Stephen FriendChairman, Co-Founder and Past President Sage Bionetworks; Leader Health Team, Apple Inc.

Stanimir HasurdjievSecretary-General of the Patient Access Partnership

17:30 – 17:45

Next Steps to Realise the Congress Conclusions

Denis HorganEAPM Executive Director

Mark LawlerChair in Translational Cancer Genomics, Queen's University Belfast, UK

2017 european union (eu) presidency event...

Documents